Glaukos Gets Approval For Glaucoma Implant, With A Catch
Label Does Not Authorize Re-Implantation Of iDose TR
Glaukos got US FDA approval for its intracameral implant of travoprost for glaucoma and hopes the product will work for up to three years. It also set a high goal for first-year sales.
